Canada
Consumer
Search
Product search
Practitioner home > Practitioner Site > Our Products

Prescribing MiSight® 1 day is Easy | CooperVision Practitioner

 

 
 
 

Start treating myopia today!


 

Treating myopia with MiSight® 1 day. Canadian Eye Care Professionals share their stories.


 

Watch Video

 

Important Product Safety Information

Learn about MiSight® 1 day for myopia control

 

Getting started with MiSight® 1 day has never been easier! The MiSightPro Center offers tools to help practices start prescribing today with in-person or on-demand guided sessions, parent conversation tips and techniques from peer doctors, staff training resources and more.

Log in to the CooperVision MiSight Pro Center, or register today to explore all that MiSight® has to offer.

Man and kid with baseball

Get Started Today!

Subscribe

* indicates required
If you are a student, please indicate your school
 
*By submitting this form, you grant CooperVision, Inc. permission to add your contact information to our database to send you information and communications related to our products and services. The use of personal contact information will be treated in accordance with CooperVision’s Privacy Policy.
 

Dual-benefit of
MiSight® 1 day:

CORRECTS BLURRY DISTANCE VISION icon

CORRECTS BLURRY DISTANCE VISION

Children wearing MiSight® 1 day achieved better than 20/20 vision across all visits over a 6-year period.*1,2

+

HELPS TREAT MYOPIA TO SLOW ITS PROGRESSION icon

HELPS TREAT MYOPIA TO SLOW ITS PROGRESSION

On average, age-appropriate children wearing MiSight® 1 day progressed less than -1.00D over 6 years.‡3

MiSight® 1 day myopia control soft contact lenses are the first FDA-approved product proven to slow myopia progression in children, aged 8-12 at the initiation of treatment

FDA-APPROVED*

MiSight® 1 day myopia control soft contact lenses are the first FDA-approved* product proven to slow myopia progression in children, aged 8-12 at the initiation of treatment.†1

Learn More

HOW MISIGHT® 1 DAY WORKS

HOW MISIGHT® 1 DAY WORKS

Take a look at how ActivControl® Technology helps reduce the rate of myopia progression in children by 59% on average.†1

Watch Video

SUPPORTED BY A 7-YEAR STUDY

SUPPORTED BY A 7-YEAR STUDY

Evidence-based medicine: See the results of the 7-year international study demonstrating a strong safety profile.*†1-4

Learn More

Myopia management is the standard of care

We can no longer let myopia get worse. Treat this disease seriously – your professional associations have spoken.5

NOVEMBER 2024

 

CAP logo

 LEARN MORE
APRIL 2021

 

World Council of Optometry logo

LEARN MORE
JUNE 2021

 

American Academy of Pediatrics logo

LEARN MORE
 
 

Vera’s Story


 

Overcoming her family history of high myopia with MiSight® 1 day.


 

Watch Now

MiSight® 1 day Resources

Healio logo

White Paper

Treating Myopia as a Disease recently published on Healio

ECP Viewpoints logo

ECP ViewpointsSM

Professional development blog and Online Success Center 

MiSight logo  

Resources for Patients

Visit the Myopia Management Center

YouTube logo

MiSight® on YouTube

Programming for Eye Care Professionals, patients and parents

Make Children's SightYour Fight™.

*Indications and Important Safety Information.
Rx only.
Results may vary.

ATTENTION: Reference the Patient Information Booklet for a complete listing of Indications and Important Safety Information.

*Only FDA approved soft contact lens designed for myopia control in the U.S.
†USA Indications for use: MiSight® 1 day (omafilcon A) soft (hydrophilic) contact lenses for daily wear are indicated for the correction of myopic ametropia and for slowing the progression of myopia in children with non-diseased eyes, who at the initiation of treatment are 8-12 years of age and have a refraction of -0.75 to -4.00 diopters(spherical equivalent) with ≤ 0.75 diopters of astigmatism. The lens is to be discarded after each removal. Canadian Indications for Use: MiSight (omafilcon A) Soft Contact Lenses for Myopia Control may reduce the rate of myopia progression in children (6-18) and correct ametropia. Reduction of myopia progression was observed in children with wearing time of 12 hours (8-16 hours) per day, 6.4 days (5-7) per week in a clinical study. Permanent myopia control after lens treatment is discontinued is not supported by clinical studies. MiSight (omafilcon A) Soft Contact Lenses for Myopia Control are indicated for single use daily disposable wear. When prescribed for daily disposable wear, the lens is to be discarded after each removal.

† Compared to a single vision 1 day lens over a 3-year period.

‡ Fitted at 8-12 years of age at initiation of treatment.

References:
1. Chamberlain P, et al. A 3-year Randomized Clinical Trial of MiSight® Lenses for Myopia Control. Optom Vis Sci. 2019; 96(8)556-567.
2. Chamberlain P, Arumugam B, Jones D et al. Myopia Progression in Children wearing Dual-Focus Contact Lenses: 6- year findings. Optom Vis Sci 2020;97(Eabstract): 200038.
3. Chamberlain P, Arumugam B, et al. Myopia progression on cessation of Dual-Focus contact lens wear: MiSight 1 day 7-year findings. Optom Vis Sci 2021;98 (Eabstract): 210049.
4. Woods, J., Jones, D., Jones, L., Jones, S., Hunt, C., Chamberlain, P., & McNally, J. (2021). Ocular health of children wearing daily disposable contact lenses over a 6-year period. Contact Lens and Anterior Eye.
5. Resolution: The standard of care for Myopia Management by Optometrists. World Council of Optometry. (2021, May 17). https://worldcouncilofoptometry.info/resolution-the-standard-of-care-for-myopiamanagement-byoptometrists.

MiSight® 1 day is a registered trademark of The Cooper Companies, Inc. and its subsidiaries.